Impel presented four scientific abstracts as part of the 2021 PAINWeek Conference held September 7-11. PAINWeek, is the largest US pain conference for frontline clinicians with an interest in pain management.

Impel presented multiple scientific abstracts as part of the 2021 American Headache Society Virtual Annual Scientific Meeting, including reoccurrence, consistency and nausea data from our pivotal Phase 3 STOP-301 trial of Trudhesa® for the acute treatment of migraine.

Impel presented five scientific abstracts as part of the 2021 Virtual American Academy of Neurology Annual Meeting, including data from our pivotal Phase 3 STOP-301 trial of Trudhesa® for the acute treatment of migraine.